Multiple myeloma: Every year a new standard?

S. Vincent Rajkumar

doi:10.1002/hon.2586

Multiple myeloma: Every year a new standard?

S. Vincent Rajkumar

Hematology

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Abstract

The treatment of myeloma is rapidly evolving. This article reviews the current diagnostic criteria, risk stratification, and approach to treatment of multiple myeloma. Treatment approach for both newly diagnosed and relapsed disease are discussed.

Original language	English (US)
Pages (from-to)	62-65
Number of pages	4
Journal	Hematological Oncology
Volume	37
Issue number	S1
DOIs	https://doi.org/10.1002/hon.2586
State	Published - Jun 2019

Keywords

myeloma
prognosis
therapy

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1002/hon.2586

Cite this

@article{9c12f4c25752450894bd7f3430b958ed,

title = "Multiple myeloma: Every year a new standard?",

abstract = "The treatment of myeloma is rapidly evolving. This article reviews the current diagnostic criteria, risk stratification, and approach to treatment of multiple myeloma. Treatment approach for both newly diagnosed and relapsed disease are discussed.",

keywords = "myeloma, prognosis, therapy",

author = "Rajkumar, {S. Vincent}",

note = "Publisher Copyright: {\textcopyright} 2019 John Wiley & Sons, Ltd.",

year = "2019",

month = jun,

doi = "10.1002/hon.2586",

language = "English (US)",

volume = "37",

pages = "62--65",

journal = "Hematological Oncology",

issn = "0278-0232",

publisher = "John Wiley and Sons Ltd",

number = "S1",

}

TY - JOUR

T1 - Multiple myeloma

T2 - Every year a new standard?

AU - Rajkumar, S. Vincent

PY - 2019/6

Y1 - 2019/6

N2 - The treatment of myeloma is rapidly evolving. This article reviews the current diagnostic criteria, risk stratification, and approach to treatment of multiple myeloma. Treatment approach for both newly diagnosed and relapsed disease are discussed.

AB - The treatment of myeloma is rapidly evolving. This article reviews the current diagnostic criteria, risk stratification, and approach to treatment of multiple myeloma. Treatment approach for both newly diagnosed and relapsed disease are discussed.

KW - myeloma

KW - prognosis

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=85066981143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066981143&partnerID=8YFLogxK

U2 - 10.1002/hon.2586

DO - 10.1002/hon.2586

M3 - Article

C2 - 31187526

AN - SCOPUS:85066981143

SN - 0278-0232

VL - 37

SP - 62

EP - 65

JO - Hematological Oncology

JF - Hematological Oncology

IS - S1

ER -

Multiple myeloma: Every year a new standard?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this